GSK outlook brightens as Brexit brings currency windfall

LONDON (Reuters) - Demand for new medicines helped GlaxoSmithKline grow earnings in the second quarter and the drugmaker is set for big gains in the rest of 2016 thanks to a weak pound, after Britain's vote to leave the European Union.

from Reuters: Top News http://uk.reuters.com/article/uk-gsk-results-idUKKCN1071C8?feedType=RSS&feedName=topNews